Genmab A/S (CPH:GMAB)
1,380.00
+8.00 (0.58%)
Jul 15, 2025, 10:32 AM CET
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
8.45M DKK
Profits / Employee
2.98M DKK
Market Cap
84.38B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,682 | 478 | 21.69% |
Dec 31, 2023 | 2,204 | 544 | 32.77% |
Dec 31, 2022 | 1,660 | 448 | 36.96% |
Dec 31, 2021 | 1,212 | 431 | 55.19% |
Dec 31, 2020 | 781 | 233 | 42.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk | 77,349 |
Coloplast | 16,639 |
Demant | 22,639 |
ALK-Abelló | 2,753 |
H. Lundbeck | 5,707 |
Zealand Pharma | 335 |
Ambu A/S | 5,196 |
Bavarian Nordic | 1,605 |
Genmab News
- 13 days ago - Genmab Announces Changes to its Executive Committee - GlobeNewsWire
- 14 days ago - Completion of Share Buy-back Program - GlobeNewsWire
- 21 days ago - Genmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As One - Seeking Alpha
- 21 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 27 days ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 27 days ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire
- 4 weeks ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 4 weeks ago - Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT) - GlobeNewsWire